Taysha Gene Therapies Inc. (TSHA)
Market Closed
1 Sep, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
5. 70
+0.01
+0.1757%
After Hours
$
+0.25 +4.386% 5. 95
1.82B Market Cap
- P/E Ratio
- Div Yield
1.76M Volume
-0.41 Eps
$ 5.69
Previous Close 
Want to track TSHA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Taysha Gene Therapies Inc. (TSHA) Statistics
Valuation metrics
Market Cap 1.82B
Enterprise value 1.45B
Trailing P/E (ttm) -13.65
Forward P/E -
PEG ratio 0.83
Price/Sales (ttm) 336.48
Price/Book (mrq) 5.5
Enterprise Value/Revenue 263.58
Enterprise Value/EBITDA -9.72
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 2.07M
Average volume (90 days) 3.96M
Price summary
52-Week low 2.71
52-Week high 7.3
Beta -
50-Day moving average 5.63
200-Day moving average 5.32
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -27.28%
Operating margin -27.92%
Operational effectiveness
Return on assets -0.32%
Return on equity -0.56%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.01
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.41
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 1.23
Total debt (mrq) -
Total Debt/Equity (mrq) 0.14
Current ratio (mrq) 17.76%
Book value per share (mrq) 1.05
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
